HomeHOFBF • OTCMKTS
add
Hofseth Biocare ASA
Market news
Financials
Income Statement
Revenue
Net income
| (NOK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 72.15M | 11.20% |
Operating expense | 57.17M | 59.62% |
Net income | -48.28M | -10.43% |
Net profit margin | -66.91 | 0.68% |
Earnings per share | — | — |
EBITDA | -33.67M | -5.07% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (NOK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 67.05M | 162.15% |
Total assets | 394.27M | 16.16% |
Total liabilities | 469.81M | 67.75% |
Total equity | -75.53M | — |
Shares outstanding | 411.08M | — |
Price to book | -0.93 | — |
Return on assets | -23.80% | — |
Return on capital | -39.15% | — |
Cash Flow
Net change in cash
| (NOK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -48.28M | -10.43% |
Cash from operations | 27.73M | -20.46% |
Cash from investing | -15.56M | -1,175.16% |
Cash from financing | -10.60M | 66.28% |
Net change in cash | 1.57M | -28.63% |
Free cash flow | 13.86M | -66.68% |
About
Founded
2000
Website
Employees
75
